Mycobacteria Registry Study: Prospective Observational Study in Austria
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLudwig Boltzmann Institute for Lung Health
About this trial
The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:
What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?
Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
individuals aged 18 years or older
written informed consent
Disqualifiers
to not comprehend and rightfully judge participation
Trial population
Any patient presenting to outpatient clinic or ward of Klink Penzing or Klinik Hietzing due to Mycobacteria infection.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Mortality
Mortality due to tuberculosis or NTM infection in Austria
Time frame
30 yearsSecondary outcomes
1
Prevalence
Prevalence of mycobacterial infections in Austria
Time frame
30 years2
Patient cohort
Description of the patient cohort
Time frame
30 years3
Risk factors
Identification of risk factors for treatment failure and complications
Time frame
30 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Ludwig Boltzmann Institute for Lung Health
Lead sponsor
Sigmund Freud PrivatUniversitat
Collaborator
Source ClinicalTrials.gov